These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 19106912)
1. [Augmentation therapy with alpha-1 antitrypsin: 20 year- follow-up of a deficient patient]. Pujazon MC; Carles P Rev Mal Respir; 2008 Nov; 25(9):1136-41. PubMed ID: 19106912 [TBL] [Abstract][Full Text] [Related]
2. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome? Abboud RT; Ford GT; Chapman KR Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045 [TBL] [Abstract][Full Text] [Related]
3. The role of augmentation therapy in alpha-1 antitrypsin deficiency. Kueppers F Curr Med Res Opin; 2011 Mar; 27(3):579-88. PubMed ID: 21226542 [TBL] [Abstract][Full Text] [Related]
4. Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers? Schwaiblmair M; Vogelmeier C Drugs Aging; 1998 Jun; 12(6):429-40. PubMed ID: 9638392 [TBL] [Abstract][Full Text] [Related]
5. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data. Lieberman J Chest; 2000 Nov; 118(5):1480-5. PubMed ID: 11083705 [TBL] [Abstract][Full Text] [Related]
6. [Characteristics of the patients included in the French cohort of patients with emphysema caused by alpha-1 antitrypsin deficiency]. Thabut G; Mornex JF; Cuvelier A; Padrazzi B; Pison C; Neukirch F; Lafitte JJ; Boczkowski J; Balduyck M; Muir JF; Carles P; Fournier M Rev Mal Respir; 2008 Nov; 25(9):1115-22. PubMed ID: 19106908 [TBL] [Abstract][Full Text] [Related]
7. Alpha-1 antitrypsin: now available, but do we need it? Russi EW Swiss Med Wkly; 2008 Apr; 138(13-14):191-6. PubMed ID: 18389391 [TBL] [Abstract][Full Text] [Related]
8. Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT. Dirksen A; Friis M; Olesen KP; Skovgaard LT; Sørensen K Acta Radiol; 1997 Sep; 38(5):826-32. PubMed ID: 9332238 [TBL] [Abstract][Full Text] [Related]
15. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis. Campos MA; Runken MC; Davis AM; Johnson MP; Stone GA; Buikema AR Adv Ther; 2018 Apr; 35(4):467-481. PubMed ID: 29616482 [TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence. Rahaghi FF; Miravitlles M Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837 [TBL] [Abstract][Full Text] [Related]